Medicare Enrolled

Dr. Arvind Neelakantan, MD

Ophthalmology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
9600 N CENTRAL EXPY STE 300, Dallas, TX 75231
2147393900
In practice since 2006 (19 years)
NPI: 1205889052 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Neelakantan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neelakantan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Neelakantan

Dr. Arvind Neelakantan is an ophthalmology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Neelakantan performed 2,660 Medicare services across 2,262 unique beneficiaries.

Between the years covered by Open Payments, Dr. Neelakantan received a total of $108,192 from 23 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Neelakantan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in TX $108,192 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,660
Medicare services
Top 35% in TX for ophthalmology
2,262
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 614 $87 $325
Office visit, established patient (20-29 min) 565 $59 $220
Visual field test, extended 401 $44 $206
Optic nerve imaging (OCT scan) 372 $26 $142
Retinal photography (fundus photo) 129 $27 $222
Exam of the internal drainage system of eye 117 $20 $85
Corneal topography and eye depth measurement 102 $19 $182
Ultrasound scan of cornea to determine thickness 90 $8 $45
New patient office visit (45-59 min) 88 $113 $500
Cataract surgery with lens implant 45 $332 $2,506
Ct scan of cornea 40 $26 $155
Laser repair to improve eye fluid flow 34 $159 $1,065
Creation of shunt to improve eye fluid flow using tissue graft 19 $896 $3,600
Removal of recurring cataract in lens capsule using a laser 18 $223 $1,050
Eye exam, established patient, focused 14 $55 $265
Comprehensive eye exam, established patient 12 $62 $385
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
18.9% medium
79.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$108,192
Total received (2018-2024)
Avg $15,456/year across 7 years
Top 4% in TX for ophthalmology
23
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,139 (91.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,333 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,720 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$564
2023
$1,204
2022
$14,854
2021
$20,967
2020
$14,872
2019
$35,496
2018
$20,235

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Aerie Pharmaceuticals, Inc.
$58,191
Bausch & Lomb, a division of Bausch Health US, LLC
$24,024
Bausch & Lomb Americas Inc.
$7,581
Alcon Vision LLC
$7,164
Allergan Inc.
$4,341
Alcon Laboratories Inc
$2,235
Allergan, Inc.
$1,054
Glaukos Corporation
$903
ABBVIE INC.
$867
NEW WORLD MEDICAL,INC.
$407
GLAUKOS CORPORATION
$311
Novartis Pharmaceuticals Corporation
$247
Carl Zeiss Meditec USA, Inc.
$227
EllexiScience
$186
Ivantis, Inc
$162
Sight Sciences, Inc.
$76
Kala Pharmaceuticals, Inc.
$66
Sun Pharmaceutical Industries Inc.
$40
Ocular Therapeutix, Inc.
$36
Thea Pharma Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Carl Zeiss Meditec, Inc.
$17
Omeros Corporation
$16
Top 3 companies account for 83.0% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · ALPHAGAN P · AcrySof · Ahmed Glaucoma Valve · BESIVANCE · CIRRUS HD-OCT · CLARUS · CLARUS 500 · CLARUS 700 · COMBIGAN · Cequa · Clareon · CyPass · DEXTENZA · DURYSTA · HYDRUS Microstent · Hydrus · IACCESS · INVELTYS · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · OMNI SURGICAL SYSTEM · Omidria · PanOptix · ReSure Sealant · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · TRAVATAN Z · VYZULTA · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iStent infinite Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for ophthalmology in TX.

Equivalent to $4,067 per 100 Medicare services performed
Looking for an ophthalmology specialist in Dallas?
Compare ophthalmologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
285
Per 100K population
10.9
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Neelakantan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Neelakantan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Neelakantan performed 614 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neelakantan receive payments from pharmaceutical companies?
Yes. Dr. Neelakantan received a total of $108,192 from 23 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neelakantan's costs compare to other ophthalmologists in Dallas?
Dr. Neelakantan's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neelakantan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →